{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:34:46Z","timestamp":1760240086195,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["GINOP-2.3.4-15-2016-00002"],"award-info":[{"award-number":["GINOP-2.3.4-15-2016-00002"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background and Aims: Diabetic cardiomyopathy (DCM) is an emerging problem worldwide due to an increase in the incidence of type 2 diabetes. Animal studies have indicated that metformin and pioglitazone can prevent DCM partly by normalizing insulin resistance, and partly by other, pleiotropic mechanisms. One clinical study has evidenced the insulin-senzitizing effect of the drug candidate BGP-15, along with additional animal studies that have confirmed its beneficial effects in models of diabetes, muscular dystrophy and heart failure, with the drug affecting chaperones, contractile proteins and mitochondria. Our aim was to investigate whether the inzulin-senzitizer BGP-15 exert any additive cardiovascular effects compared to metformin or pioglitazone, using Goto-Kakizaki (GotoK) rats. Methods: Rats were divided into five groups: (I) healthy control (Wistar), (II) diseased (GotoK), and GotoK rats treated with: (III) BGP-15, (IV) metformin, and (V) pioglitazone, respectively, for 12 weeks. Metabolic parameters and insulin levels were determined at the endpoint. Doppler echocardiography was carried out to estimate diabetes-associated cardiac dysfunction. Thoracotomy was performed after the vascular status of rats was evaluated using an isolated aortic ring method. Furthermore, western blot assays were carried out to determine expression or phosphorylation levels of selected proteins that take part in myocyte relaxation. Results: BGP-15 restored diastolic parameters (e\u2032\/a\u2032, E\/e\u2032, LAP, E and A wave) and improved Tei-index compared to untreated GotoK rats. Vascular status was unaffected by BGP-15. Expression of sarco\/endoplasmic reticulum Ca2+-ATPase (SERCA2a) and phosphodiesterase 9A (PDE9A) were unchanged by the treatments, but the phosphorylation level of vasodilator-stimulated phosphoprotein (VASP) and phospholamban (PLB) increased in BGP-15-treated rats, in comparison to GotoK. Conclusions: Even though the BGP-15-treatment did not interfere significantly with glucose homeostasis and vascular status, it considerably enhanced diastolic function, by affecting the SERCA\/phospholamban pathway in GotoK rats. Although it requires further investigation, BGP-15 may offer a new therapeutic approach in DCM.<\/jats:p>","DOI":"10.3390\/molecules24030586","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T11:50:33Z","timestamp":1549540233000},"page":"586","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy"],"prefix":"10.3390","volume":"24","author":[{"given":"Mariann","family":"Bombicz","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5818-4557","authenticated-orcid":false,"given":"Daniel","family":"Priksz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-055X","authenticated-orcid":false,"given":"Rudolf","family":"Gesztelyi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-366X","authenticated-orcid":false,"given":"Rita","family":"Kiss","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Hollos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Nemeth","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Toth","sequence":"additional","affiliation":[{"name":"Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Papp","sequence":"additional","affiliation":[{"name":"Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Szilvassy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Juhasz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIR.0000000000000034","article-title":"Type 1 diabetes mellitus and cardiovascular disease: A scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"Fonseca","year":"2014","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CS20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon?","volume":"131","author":"Tate","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/derm.22028","article-title":"Advanced glycation end products: Key players in skin aging?","volume":"4","author":"Gkogkolou","year":"2012","journal-title":"Dermato-Endocrinology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","article-title":"Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase","volume":"53","author":"Bidasee","year":"2004","journal-title":"Diabetes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Brit. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1113\/expphysiol.2011.058271","article-title":"Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat","volume":"96","author":"Howarth","year":"2011","journal-title":"Expe. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00395-004-0440-4","article-title":"Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus","volume":"99","author":"Yang","year":"2004","journal-title":"Basic Res. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/5584_2017_105","article-title":"Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy","volume":"1067","author":"Alonso","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1476-5381.2011.01230.x","article-title":"Metformin restores endothelial function in aorta of diabetic rats","volume":"163","author":"Sena","year":"2011","journal-title":"Brit. J. pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S1262-3636(03)72796-7","article-title":"Metformin and vascular protection: A cardiologist\u2019s view","volume":"29","author":"Libby","year":"2003","journal-title":"Diabetes Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/ATVBAHA.112.300346","article-title":"Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors","volume":"33","author":"Saremi","year":"2013","journal-title":"Arterioscl. Throm. Vas."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1753425913501565","article-title":"Pioglitazone reduces inflammation through inhibition of NF-kappaB in polymicrobial sepsis","volume":"20","author":"Kaplan","year":"2014","journal-title":"Innate immune."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10980","article-title":"Hsp72 preserves muscle function and slows progression of severe muscular dystrophy","volume":"484","author":"Gehrig","year":"2012","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1038\/ncomms6705","article-title":"The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice","volume":"5","author":"Sapra","year":"2014","journal-title":"Nat. commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10974-018-9495-y","article-title":"BGP-15 improves contractile function of regenerating soleus muscle","volume":"39","author":"Nascimento","year":"2018","journal-title":"J. Muscle Res. Cell M."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/met.2013.0098","article-title":"Improvement of insulin sensitivity by a novel drug candidate, BGP-15, in different animal studies","volume":"12","author":"Tory","year":"2014","journal-title":"Metabo. Syndr. Relat. D."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"350ra103","DOI":"10.1126\/scitranslmed.aaf7099","article-title":"The chaperone co-inducer BGP-15 alleviates ventilation-induced diaphragm dysfunction","volume":"8","author":"Salah","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4239\/wjd.v4.i5.177","article-title":"Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management","volume":"4","author":"Pappachan","year":"2013","journal-title":"World J. diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"Jama"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"728741","DOI":"10.1155\/2015\/728741","article-title":"An altered pattern of myocardial histopathological and molecular changes underlies the different characteristics of type-1 and type-2 diabetic cardiac dysfunction","volume":"2015","author":"Radovits","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kuwabara, W.M.T., Panveloski-Costa, A.C., Yokota, C.N.F., Pereira, J.N.B., Filho, J.M., Torres, R.P., Hirabara, S.M., Curi, R., and Alba-Loureiro, T.C. (2017). Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus?. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189622"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/dc05-2226","article-title":"Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes","volume":"29","author":"Sourij","year":"2006","journal-title":"Diabetes care"},{"key":"ref_25","first-page":"853","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"3","author":"Hadi","year":"2007","journal-title":"Vascular health risk manage."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1463-1326.2002.00212.x","article-title":"Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes","volume":"4","author":"Wen","year":"2002","journal-title":"Diabetes Obes. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/15733998113099990069","article-title":"Goto-Kakizaki rats: Its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus","volume":"9","author":"Akash","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2165\/11538100-000000000-00000","article-title":"Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: Comparison with other oral antihyperglycaemic agents","volume":"70","author":"Derosa","year":"2010","journal-title":"Drugs"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2337\/diabetes.46.9.1393","article-title":"Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa\/fa rat","volume":"46","author":"Hallakou","year":"1997","journal-title":"Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.289.2.187","article-title":"Years of life lost due to obesity","volume":"289","author":"Fontaine","year":"2003","journal-title":"Jama"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-500X.107656","article-title":"Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial","volume":"4","author":"Chawla","year":"2013","journal-title":"J. Pharmacol. Pharmacot."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e013927","DOI":"10.1136\/bmjopen-2016-013927","article-title":"Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: A systematic review and meta-analysis","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiog."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1038\/emm.2013.58","article-title":"Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats","volume":"45","author":"Oh","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2008.06.013","article-title":"The GK rat beta-cell: A prototype for the diseased human beta-cell in type 2 diabetes?","volume":"297","author":"Portha","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2009.09.003","article-title":"Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats","volume":"623","author":"Yoshida","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: Pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_38","first-page":"169","article-title":"Use and Limitations of E\/e\u2019 to Assess Left Ventricular Filling Pressure by Echocardiography","volume":"19","author":"Park","year":"2011","journal-title":"J. Card."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.1998.tb08258.x","article-title":"Phosphorylation states of phospholamban","volume":"853","author":"Colyer","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.107.158873","article-title":"Is phospholamban or troponin I the \"prima donna\" in beta-adrenergic induced lusitropy?","volume":"101","author":"Murphy","year":"2007","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/eurheartj\/ehr445","article-title":"Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I","volume":"34","author":"Frantz","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00395-010-0097-0","article-title":"Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia\/reoxygenation","volume":"105","author":"Gorbe","year":"2010","journal-title":"Basic Rese. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20029","DOI":"10.1074\/jbc.273.32.20029","article-title":"Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody","volume":"273","author":"Smolenski","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Priksz, D., Bombicz, M., Varga, B., Kurucz, A., Gesztelyi, R., Balla, J., Toth, A., Papp, Z., Szilvassy, Z., and Juhasz, B. (2018). Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102882"},{"key":"ref_46","first-page":"917","article-title":"Identification of PPARgamma ligands with One-dimensional Drug Profile Matching","volume":"7","author":"Kovacs","year":"2013","journal-title":"Drug Des, Dev. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Szabo, K., Gesztelyi, R., Lampe, N., Kiss, R., Remenyik, J., Pesti-Asboth, G., Priksz, D., Szilvassy, Z., and Juhasz, B. (2018). Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030798"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/3\/586\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:31:28Z","timestamp":1760185888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/3\/586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["molecules24030586"],"URL":"https:\/\/doi.org\/10.3390\/molecules24030586","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2019,2,7]]}}}